| Antibiotic Classes and Activity | ||||||||||||||||||
| Go to Comparison of Antifungals | ||||||||||||||||||
| Return to Main Index | ||||||||||||||||||
| Bacteria by classification | Gram Postive | Gram Negative | Anaerobes | Atypical | Other | |||||||||||||
| Cocci: Staphylcocci (clusters), S. pneumoniae (pairs), Group and viridans streptococci (chains), Enterococcus sp (pairs and chains); Bacilli: Bacillus sp, Corynebacterium sp, Listeria monocytogenes, Nocardia sp | Cocci: Moraxella catarrhalis, Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae Bacilli: E. coli, Enterobacter sp, Citrobacter, Klebsiella sp, Proteus sp, Serratia, Salmonella, Shigella, Acinetobacter, Helicobacter, Pseudomonas aeruginosa | Above diaphragm: Peptococcus sp, Peptostreptoccus sp, Prevotella, Veillonella, Actinomyces Below diaphragm: Clostridium perfringens, tetani, & difficile, Bacteroides fragilis, disastonis, ovatus, & thetaiotamicron, Fusobacterium | Legionella pneumophilia, Mycoplasma pneumoniae or hominis, Chlamydia pneumoniae or trachomatis | Treponema pallidium (syphillis), Borrelia burgdorferi (Lyme) | ||||||||||||||
| Bacteria by infection site | Mouth | Skin/Soft Tissue | Bone and Joint | Abdomen | Urinary Tract | Upper Respiratory | Lower Respiratory | Meningitis | ||||||||||
| Peptococcus, Peptostreptococcus, Actinomyces | S. aureus, S. pyogenes, S. epidermidis, Pasteurella | S. aureus, S. epidermidis, Steptococci, N. gonorrhoeae, Gram-negative rods | E. coli, Proteus, Klebsiella, Enterococcus, Bacteroides sp | E. coli, Proteus, Klebsiella, Enterococcus, Staph saprophyticus | Community: S. pneumoniae, H. influenzae, K. pneumoniae, Legionella pneumophilia, Mycoplasma, Chlamydia Hospital: K. pneumoniae, P. aeruginosa, Enterobacter sp, Serratia sp, S. aureus | S. pneumoniae, N. meningitis, H. influenzae, Group B streptococcus, E. coli, Listeria | ||||||||||||
| Common Pathogens by Disease | ||||||||||||||||||
| Activity | ||||||||||||||||||
| Antibiotic Class | Drugs in Class | Mechanism of Action | Gram Positive | Gram Negative | Anaerobes | Atypical | Other | |||||||||||
| Penicillins | Penicillin G, Penicillin VK | Inhibits cell wall synthesis by binding to penicillin-binding proteins (PBP) which are located in bacterial cell walls Are bactericidal (except against enterococcus). | Penicillin-susceptible S. Aureus & S. Pneumoniae, Group streptococci, viridans, streptococci, enterococcus | Neisseria sp. | Above diaphragm sp (see above), Clostridium sp | None | Treponema pallidum (syphilis) | |||||||||||
| Penicillinase-Resistant Penicillins | Nafcillin, Oxacillin, Methicillin | Same as above, except these were designed to overcome the penicillinase enzyme of S. aureus which inactivated natural penicillins | Methicillin-susceptable S. aureus, Group streptococci, Viridans streptococci | None | None | None | None | |||||||||||
| Aminopenicillins | Ampicillin, Amoxicillin | Same as above. Developed to have increased activity against gram-negative aerobes | Penicillin-susceptible S. Aureus, Group streptococci, viridans streptococci, Enterococcus sp, Listeria monocytogenes | Proteus mirabilis, Salmonella, Shigella, some E. coli, some H. influenzae | None | None | None | |||||||||||
| Carboxypenicillins | Carbenicillin, Ticarcillin | Same as above. Have increased activity against resistant gram-negative aerobes than Aminopenicillins | Marginal activity | Proteus mirabilis, Salmonella, Shigella, some E. coli, some H. influenzae, Enterobacter sp, Pseudomonas aeruginosa | None | None | None | |||||||||||
| Ureidopenicillins | Piperacillin, Azlocillin | Same as above. Have greater activity against resistant gram-negative aerobes than Carboxypenicillins | Viridans strep., Group strep, some Enterococcus | Proteus mirabilis, Salmonella, Shigella, E. coli, some H. influenzae, Enterobacter sp, Pseudomonas aeruginosa, Serratia marcescens, some Klebsiella sp | Fairly good activity | |||||||||||||
| B-Lactamase Inhibitor Combinations | Unasyn, Augmentin, Timentin, Zosyn | Same as above. Have greater activity against B-lactamase producing organisms | S. aureus | H. influenzae, E. coli, Proteus sp, Klebsiella sp, Neisseria gonorrhoeae, Moraxella catarrhalis | Bacteroides sp | |||||||||||||
| First generation cephalosporins | Duricef, Kefzol, Keflex, Cephalothin, Velosef | Inhibits cell wall synthesis by binding to penicillin-binding proteins (PBP) which are located in bacterial cell walls Best activity of cephalosporins against gram-positive/limited against gram-negative. Are bactericidal. | Methicillin-susceptable S. aureus, Penicillin-susceptable S. pneumoniae, Group streptococci, Viridans streptococci | E. coli, K. pneumoniae, P. mirabilis | ||||||||||||||
| Second generation cephalosporins | Ceclor, Mandol, Zefazone, Precef, Cefotan, Mefoxin, Cefzil, Ceftin, Zinacef, Lorabid | Same as above. Slightly less active against gram-positive, but more active against gram-negative and some anaerobic activity. Are bactericidal. | Methicillin-susceptable S. aureus, Penicillin-susceptable S. pneumoniae, Group streptococci, Viridans streptococci | E. coli, K. pneumoniae, P. mirabilis, H. influenzae, M. catarrhalis, Neisseria sp | Bacteroides fragilis, Bacteroides fragilis group - only with cefotan, mefoxin, & zefazone | |||||||||||||
| Third generation cephalosporins | Omnicef, Suprax, Claforan, Vantin, Cefizox, Rocephin, Fortaz | Same as above. Less active than second generation against gram-positive, but more active against gram-negative. Rocephin & Claforan have best activity against gram-positive (including pen-resistant S. pneumoniae). Are bactericidal. | E. coli, K. pneumoniae, P. mirabilis, H. influenzae, M. catarrhalis, Neisseria gonorrhoeae (including B-lactamase producing), N. meningitdis, Citrobacter sp, Enterobacter sp, Acineobacter sp, Morganella morganii, Serratia marcescens, Providencia, Pseudomonas aeruginosa (Fortaz) | |||||||||||||||
| Fourth generation cephalosporins | Maxipime | Same as above. Extended spectum of activity. Are bactericidal. | Similar to Rochepin (see above) | Similar to Fortaz (see above) | ||||||||||||||
| Carbapenems | Merrem, Primaxin, Invanz | Inhibits cell wall synthesis by binding to penicillin-binding proteins (PBP) which are located in bacterial cell walls. Are bactericidal. | Good coverage; does not cover MRSA, VRE, coagulase-negative staph, or Nocardia | Good coverage; does not cover S. maltophilia | Good coverage; does not cover C. difficile | None | None | |||||||||||
| Monobactams | Azactam | Same as above, except these bind preferentially to PBP-3 of gram negative aerobes. Are bactericidal. | Little to no activity | E. coli, K. pneumoniae, P., mirabilis, S. marcescens, H. influenzae, M. catarrhalis, Enterobacter, Citrobacter, Providencia, Morganella, Salmonella, Shigella, Pseudomonas aeruginosa | Little to no activity | None | None | |||||||||||
| Fluoroquinalones | Olders agents: Noroxin, Cipro Newer agents: Levaquin, Tequin, Avelox, Trovan, Factive | Inhibit bacterial topoisomerases which are necessary for DNA synthesis. Primary target for gram-positive bacteria is DNA gyrase, and primary target for gram-negative bacteria is Topoisomerase IV. Concentration-dependant bactericidal activity | Older agents have poor activity. Newer agents cover MSSA, Strep pneumoniae (including PRSP), group and viridans steptococci (limited activity), and Enterococci sp (limited activity) | All have excellent activity (cipro=levo>gati>moxi). Cover E. coli, Klebsiella sp, Enterobacter sp, Proteus sp, Salmonella, Shigella, Serratia marcescens, and other enterobacteriaceae; H. influenzae, M. catarrhalis, Neisseria sp, Pseudomonas aeruginosa (significant resistance - cipro & levaquin have best activity) | Only Trovan has activity against Bacteroides sp | All have excellent activity against atypical including: Legionella pneumonia (drugs of choice), Chlamydia sp, Mycoplasma sp, Ureoplasma urealyticum | Mycobacterium tuberculosis, Bacillus anthracis | |||||||||||
| Macrolides | Erythromycin, Zithromax, Biaxin | Inhibits protein synthesis by reversibly binding to the 50S ribosomal subunit. Suppression of RNA-dependent protein synthesis. Bacteriostatic activity | (biaxin>e-mycin>zithro) MSSA, strep pneumoniae (only PSSP - resistance developing), group and viridans steptococci, bacillus sp, corynebacterium sp | (zithro>biaxin>e-mycin) H. influenzae (not e-mycin), M. catarrhalis, Neisseria sp. Do not have any activity against any enterobacteriaceae | Activity against Peptococcus sp, Peptosteptococcus sp, Prevotella, Veillonella, Actinomyces | All have excellent activity against atypical including: Legionella pneumonia (drugs of choice), Chlamydia sp, Mycoplasma sp, Ureoplasma urealyticum | Mycobacterium avium complex (MAC - only A and C), Treponema pallidum, Campylobacter, Borrelia, Bordetella, Brucella, Pasteurella | |||||||||||
| Aminoglycosides | Gentamicin, Tobramycin, Amikacin, Kantrex, Neomycin, Steptomycin | Irreversibly bind to 30S ribosomes, which disrupt the initiation of protein synthesis, decreases overall protein synthesis, and produces misreading of mRNA. Are bactericidal | most S. aureus and coagulase-negative staph, viridans steptococci, enterococcus sp | All but steptomycin: E. coli, K. pneumoniae, Proteus sp, Acinetobacter, Citrobacter, Enterobacter sp, Morganella, Providencia, Serratia, Salmonella, Shigella, Pseudomonas aeruginosa (amik>tobra>gent) | None | Coverage with amikacin and streptomycin | Mycobacterium tuberculosis - streptomycin | |||||||||||
| Vancomycin | Vancomycin | Binds to D-alanyl-D-alanine portion of cell wall precursors to inhibit synthesis and assembly of the second stage of peptidoglycan polymers. Are bactericidal (except for Enterococcus) | MSSA, MRSA, coagulase-negative staph, Strept pneumoniae (including PRSP), Viridans streptococcus, Group streptococcus, Enterococcus sp, Corynebacterium, Bacillus, Listeria | None | Actinomyces, Clostridium sp (including C. difficile), Peptococcus, Peptostreptococcus | None | None | |||||||||||
| Streptogramins | Synercid | Each agent (quinupristin/dalfopristin) acts on 50S ribosomal subunits to inhiit early and late stages of protein synthesis. It is bacteriostatic | MSSA, MRSA, coagulase-negative staph, Strept pneumoniae (including PRSP), Viridans streptococcus, Group streptococcus, Enterococcus faecium (only), Corynebacterium, Bacillus, Listeria | Limited activity against Neisseria sp, and Moraxella | Actinomyces, Clostridium sp (except C. difficile), Peptococcus, Peptostreptococcus | Mycoplasma, Legionella | None | |||||||||||
| Oxazolidinones | Zyvox | Binds to the 50S ribosomal subunit near to surface interface of 30S subunit, which causes inhibition of 70S initiation complex which inhibts protein synthesis. It is bacteriostatic | MSSA, MRSA, VRSA, coagulase-negative staph, strep pneumoniae (including PRSP), viridans streptococcus, Group streptococcus, Enterococcus faecium and faecalis (including VRE), Bacillus, Listeria | Relatively inactive | Clostridium sp (except C. difficile), Peptostreptococcus, P. acnes | Mycoplasma, Chlamydia, Legionella | None | |||||||||||
| Lincosamide | Clindamycin, Lincocin | Binds to 50S ribosomal subunit to inhibit protein synthesis. Typically is bacteriostatic. | MSSA, Strep pneumoniae (PSSP only), Group and viridans streptococci | None | Peptostreptococcus, some Bacteroides sp, Actinomyces, Prevotella sp, Propionibacterium, Fusobacterium, Clostridium sp (not C. difficile) | None | Pneumocystis carinii, Toxoplasmosis gondii, Malaria | |||||||||||
| Metronidazole | Flagyl | Prodrug which is activated by a reductive process. It have selective toxicity against anaerobic and microaerophilic bacteria due to the presence of ferredoxins within these bacteria. It it bactericidal. | None | None | Bacteria: Bacteroides sp (all), Fusobacterium, Prevotella sp, Clostridium sp (all), Helicobacter pylori; Protozoa: Trichomonas vaginalis, Entamoeba histolytica, Giardia lamblia, Gardnerella vaginalis | None | None | |||||||||||
| Glycylcyclines | Tygacil | Reversibly binds to the A site of the 30S ribosomal subunit. It is bacteriostatic, but demonstrates bactericidal activity against certain pathogens | Enterococcus faecalis, Enterococcus faecium (both VRE and non-VRE), Staph aureus (both MRSA and MSSA), Streptococcus pneumoniae (both PCN susceptible and PCN resistant) | Acinetobacter baumannii, Enterobacter cloacae, Enterobacteriaceae sp, E. coli (both ESBL and non-ESBL), H. influenzae (both BL positive and negative), K. pneumoniae (both ESBL and non-ESBL), P. aueruginosa, S. marcescens | Fusobacterium sp, Prevotella sp, Peptostreptococcus sp, C. difficile | None | None | |||||||||||
| Cyclic Lipopeptide | Cubicin | Binds to components of the cell membrane of susceptible organisms and causes rapid depolarization, inhibiting intracellular synthesis of DNA, RNA, and protein. It is bactericidal in a concentration dependent manner | MSSA, MRSA, coagulase negative staphylococci, oxacillin-resistant S. aureus & S. epidermidis, PCN susp & resistant S. pneumoniae, viridans steptococci, streptococcus sp, VSE, VRE | None | None | None | None | |||||||||||